Angebote zu "Leukemia" (8 Treffer)

Kategorien

Shops

Chronic Lymphocytic Leukemia
250,90 CHF *
ggf. zzgl. Versand

Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the Western world. It is also the prototype of B-cell chronic lymphoid malignancies and of their ramifications within the fields of hematology, immunology and oncology. For a long time the Cinderella of lymphoid malignancies CLL has now become the focus of major interest and an increasing number of investigators from different areas, including genetics, molecular biology, basic and applied immunology are becoming actively engaged in the investigation of CLL. Clinicians are considering CLL as a very interesting target of many projects which aim at translating the new and exciting developments of basic science into effective new approaches to the patient. TOC:B Cell Development and Its Deregulation to Transformed States at the Pre B Cell Receptor - Expressing Pre BII Cell Stage.- Gene Expression Patterns in Human and Mouse B Cell Development.- New Insights Into the Phenotype and Cell Derivation of B-Cell Chronic Lymphocytic Leukemia.- Chronic Lymphocytic Leukemia: Molecular Genetics and Animal Models.- What Do Somatic Hypermutation and Classic Switch Recombination Teach Us About Chronic Lymphocytic Leukemia Pathogenesis.- Chronic Lymphocytic Leukemia: A Review of the Immunoarchitecture.- Clinical and Laboratory Parameters That Define B-CLL Subgroups of Clinical Relevance.- Differential Effects on CLL Cell Survival Exerted by Different Microenvironmental Elements.- Genotypic Prognostic Markers.- Chronic Lymphocytic Leukemia: Clinical Translations of Biological Features.- Subject Index.

Anbieter: Orell Fuessli CH
Stand: 05.12.2019
Zum Angebot
Chronic Lymphocytic Leukemia
202,29 € *
ggf. zzgl. Versand

Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the Western world. It is also the prototype of B-cell chronic lymphoid malignancies and of their ramifications within the fields of hematology, immunology and oncology. For a long time the Cinderella of lymphoid malignancies CLL has now become the focus of major interest and an increasing number of investigators from different areas, including genetics, molecular biology, basic and applied immunology are becoming actively engaged in the investigation of CLL. Clinicians are considering CLL as a very interesting target of many projects which aim at translating the new and exciting developments of basic science into effective new approaches to the patient. TOC:B Cell Development and Its Deregulation to Transformed States at the Pre B Cell Receptor - Expressing Pre BII Cell Stage.- Gene Expression Patterns in Human and Mouse B Cell Development.- New Insights Into the Phenotype and Cell Derivation of B-Cell Chronic Lymphocytic Leukemia.- Chronic Lymphocytic Leukemia: Molecular Genetics and Animal Models.- What Do Somatic Hypermutation and Classic Switch Recombination Teach Us About Chronic Lymphocytic Leukemia Pathogenesis.- Chronic Lymphocytic Leukemia: A Review of the Immunoarchitecture.- Clinical and Laboratory Parameters That Define B-CLL Subgroups of Clinical Relevance.- Differential Effects on CLL Cell Survival Exerted by Different Microenvironmental Elements.- Genotypic Prognostic Markers.- Chronic Lymphocytic Leukemia: Clinical Translations of Biological Features.- Subject Index.

Anbieter: Thalia AT
Stand: 05.12.2019
Zum Angebot
Responses of CLL cells to purine analogs with c...
21,99 € *
ggf. zzgl. Versand

Our findings demonstrate the need of ex vivo chronic lymphocytic leukemia cell (CLL) treatment before the application of drugs to select the most efficient manner of the patient's therapy. The obtained results confirm the link between the outcomes of the research done under ex vivo and in vivo conditions and underline the usefulness of ex vivo studies in the individual choice of CLL treatment. Our observations provide a base for further studies on the relationship between the in vivo clinical responses of patients and ex vivo pro-apoptotic activity, and the cytotoxicity of drugs against leukemic cells. Their validation by a study comprising a much larger group of patients is needed.

Anbieter: Thalia AT
Stand: 05.12.2019
Zum Angebot
Umbelliprenin and Chronic Lymphocytic Leukemia ...
28,90 € *
ggf. zzgl. Versand

Umbelliprenin and Chronic Lymphocytic Leukemia (CLL) Treatment ab 28.9 EURO

Anbieter: ebook.de
Stand: 05.12.2019
Zum Angebot
Umbelliprenin and Chronic Lymphocytic Leukemia ...
28,90 € *
ggf. zzgl. Versand

Umbelliprenin and Chronic Lymphocytic Leukemia (CLL) Treatment ab 28.9 € als Taschenbuch: . Aus dem Bereich: Bücher, Wissenschaft, Medizin,

Anbieter: hugendubel
Stand: 05.12.2019
Zum Angebot
Chronic Lymphocytic Leukemia
66,99 € *
ggf. zzgl. Versand

This book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. All aspects are considered, including pathophysiology, clinical presentation, diagnosis, prognosis, treatment, follow-up, and complications and their management. Readers will find important information on the various prognostic markers as well as practical guidance on the use of different diagnostic procedures. A key focus of the book is the changing treatment paradigm in CLL as progress in understanding of pathogenesis and pathophysiology leads to the identification of new potential therapeutic targets. General treatment concepts are clearly described, and it is explained how choice of treatment for CLL depends on stage, age, and performance status as well as specific genetic aberrations. In addition, frontline therapeutic strategies for disease relapse, including allogeneic stem cell transplantation, are reported. Looking beyond CLL, the diagnosis and therapy of T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed.

Anbieter: buecher
Stand: 05.12.2019
Zum Angebot
Chronic Lymphocytic Leukemia
66,99 € *
ggf. zzgl. Versand

This book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. All aspects are considered, including pathophysiology, clinical presentation, diagnosis, prognosis, treatment, follow-up, and complications and their management. Readers will find important information on the various prognostic markers as well as practical guidance on the use of different diagnostic procedures. A key focus of the book is the changing treatment paradigm in CLL as progress in understanding of pathogenesis and pathophysiology leads to the identification of new potential therapeutic targets. General treatment concepts are clearly described, and it is explained how choice of treatment for CLL depends on stage, age, and performance status as well as specific genetic aberrations. In addition, frontline therapeutic strategies for disease relapse, including allogeneic stem cell transplantation, are reported. Looking beyond CLL, the diagnosis and therapy of T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed.

Anbieter: buecher
Stand: 05.12.2019
Zum Angebot